newsfilter
← Latest News
GlobeNewswire·

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement

Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics (NASDAQ:QLGN) (the "Company" or "Qualigen") today announced that the Company received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") that